Master The Supreme Court held that HMO physicians' mixed eligibility-and-treatment decisions are not fiduciary acts under ERISA and therefore do not support ERISA breach-of-fiduciary-duty claims. with this comprehensive case brief.
Pegram v. Herdrich is a landmark ERISA and health law decision addressing whether an HMO's internal financial incentives—and the bedside judgments influenced by them—can form the basis of a federal fiduciary-duty claim under ERISA. The case arose from an HMO physician's decision to delay an ultrasound in order to have it performed at a facility within the HMO's network, an eight-day delay during which the patient's appendix ruptured. The plaintiff argued that the incentive structures driving that decision amounted to a breach of ERISA fiduciary duties owed by the HMO and its physicians to plan participants.
The Supreme Court unanimously rejected that theory, explaining that when physicians in HMOs make "mixed eligibility and treatment decisions," they are not acting as ERISA fiduciaries. Congress, the Court emphasized, contemplated that HMOs would control costs and use incentive mechanisms; converting routine medical judgment into an ERISA fiduciary function would federalize malpractice and unravel HMO operations. Pegram thus draws a critical boundary in ERISA: it confines fiduciary obligations to plan administration and management, leaving medical decision-making—and challenges to it—largely to state tort law and regulatory regimes.
Pegram v. Herdrich, 530 U.S. 211 (2000) (U.S. Supreme Court)
Cynthia Herdrich received medical care through the Carle Clinic Association, an HMO in Illinois in which its physicians had financial incentives to minimize costs, including internal referral requirements and profit-sharing based on efficient utilization. After developing lower abdominal pain, Herdrich's HMO physician, Dr. Lori Pegram, suspected appendicitis but ordered an ultrasound to be performed eight days later at a Carle-affiliated facility, rather than immediately at a local hospital outside the HMO network. Before the scheduled test, Herdrich's appendix ruptured, causing peritonitis and serious complications. Herdrich sued in Illinois state court for malpractice and also pursued a federal claim alleging that Carle, Dr. Pegram, and related entities breached fiduciary duties under ERISA by structuring and acting under financial incentives that encouraged under-provision of care. The district court dismissed the ERISA fiduciary-duty claim. On rehearing en banc, the Seventh Circuit reversed, holding that the incentive arrangements could constitute a fiduciary breach under ERISA. The defendants sought and obtained Supreme Court review.
Are HMO physicians and organizations acting as ERISA fiduciaries when they make mixed eligibility-and-treatment decisions influenced by internal cost-containment incentives, such that patients may sue under ERISA for breach of fiduciary duty?
Under ERISA, a person is a fiduciary only to the extent they exercise discretionary authority or control over plan management or assets, or have discretionary responsibility in the administration of the plan (29 U.S.C. § 1002(21)(A)). Medical judgments by HMO physicians, including mixed eligibility-and-treatment decisions at the point of care—even when influenced by cost-containment incentives—are not fiduciary acts under ERISA and cannot support ERISA breach-of-fiduciary-duty claims.
No. The Supreme Court held unanimously that HMO physicians' mixed eligibility-and-treatment decisions are not ERISA fiduciary acts. Consequently, ERISA does not provide a cause of action for breach of fiduciary duty based on those decisions or the incentive structures that influence them. The Court reversed the Seventh Circuit.
The Court, per Justice Souter, began by distinguishing plan administration from medical treatment. ERISA imposes fiduciary duties on those administering and managing plans, not on physicians exercising professional judgment in treating patients. While pure eligibility decisions about whether a plan covers a particular service can be fiduciary when made by plan administrators, physicians in HMOs routinely make mixed determinations at the bedside—deciding both what care is clinically appropriate and whether it is covered or should be provided within a network setting. Treating those mixed eligibility-and-treatment judgments as ERISA fiduciary acts would impermissibly transform ordinary malpractice and utilization decisions into federal fiduciary litigation. Congress anticipated that HMOs would use cost-containment mechanisms such as capitation and internal referral incentives; recognizing fiduciary liability for every medical decision influenced by such incentives would effectively outlaw HMOs or force them to abandon core features Congress expected, undermining the structure of managed care. The Court cautioned against creating federal common-law causes of action that would disrupt this legislative balance. The Court also noted practical and doctrinal concerns: ERISA fiduciary standards are ill-suited to evaluate medical negligence or clinical balancing of cost and care, which traditionally fall within state tort law and medical regulation. Expanding ERISA to cover bedside judgments would federalize malpractice, distort remedies, and conflict with ERISA's remedial scheme, which does not provide extracontractual damages for personal injuries. Finally, while ERISA reaches misrepresentations or mal-administration by plan fiduciaries, the claim here attacked the HMO's fundamental incentive design and physicians' medical decisions, neither of which constitutes fiduciary conduct under ERISA. Because the alleged wrongs were not fiduciary in nature, the ERISA breach-of-fiduciary-duty claim could not proceed.
Pegram v. Herdrich sets a key boundary in ERISA litigation by clarifying that HMO physicians' mixed eligibility-and-treatment decisions are not fiduciary acts. The decision preserves space for state malpractice and health-care regulation to govern medical negligence and ensures ERISA fiduciary duties remain tethered to plan management and administration. It also validates the use of cost-containment incentives in HMOs, absent separate wrongdoing such as misrepresentation or improper plan administration. For students, Pegram is foundational for understanding ERISA's fiduciary framework, the treatment/eligibility distinction, and how federal ERISA claims interact with state malpractice law and later ERISA preemption jurisprudence.
A mixed decision occurs when a physician simultaneously exercises medical judgment about what care is appropriate and decides whether, where, or how that care will be provided under the plan—such as opting to perform a test within an HMO's network facility at a later time instead of immediately at an out-of-network hospital. These bedside judgments blend clinical and coverage considerations and, under Pegram, are not ERISA fiduciary acts.
No. The Court held only that such incentives do not create ERISA fiduciary liability when they influence mixed medical decisions. Incentive structures remain subject to state regulation, professional standards, malpractice suits for negligent care, and potential ERISA liability if they are implemented through fiduciary misrepresentation or improper plan administration. Pegram simply rejects repackaging medical negligence or incentive-influenced bedside decisions as ERISA fiduciary breaches.
Pegram focuses on fiduciary status, not preemption. By classifying mixed medical decisions as non-fiduciary, it implicitly leaves such claims to state law (e.g., malpractice). Later cases address preemption more directly, but Pegram supports the view that claims targeting the quality of medical care, rather than enforcing plan terms, typically proceed under state tort law rather than ERISA.
Actions involving plan administration or management—such as misrepresenting coverage, improperly denying benefits in an administrative capacity, mismanaging plan assets, or violating disclosure duties—can constitute fiduciary breaches. The key is whether the defendant was acting in a fiduciary capacity under ERISA's definition when engaging in the challenged conduct.
The Seventh Circuit treated HMO incentive structures influencing physician decisions as potential ERISA fiduciary breaches. The Supreme Court rejected that premise, reasoning that physicians' mixed bedside judgments are not fiduciary functions and that Congress contemplated cost-containment in HMOs. Expanding fiduciary liability as the Seventh Circuit suggested would federalize malpractice and undermine the managed-care model Congress expected.
Pegram v. Herdrich draws a bright line between ERISA plan administration and the practice of medicine. By holding that HMO physicians' mixed eligibility-and-treatment decisions are not fiduciary acts, the Court preserved the traditional domain of state malpractice law for claims about the quality and timing of medical care while confining ERISA fiduciary duties to plan management and administration.
For law students, Pegram is essential to understanding ERISA's functional definition of "fiduciary," the limits of federal remedies for personal injuries arising from medical decisions, and the policy balance Congress struck in facilitating managed care. The decision continues to guide courts in differentiating between coverage administration (potentially fiduciary) and bedside medical judgment (not fiduciary) within the complex interplay of ERISA and health care delivery.
Need to cite this case?
Generate a perfectly formatted Bluebook citation in seconds.
Use our Bluebook Citation Generator →